Episodes (Page 28)
✨
Review of latest GOLD guidelines for COPD.
Bing Xue
✨
Experts discuss the need for EU medtech agency.
✨
Discussion of Cerba Research's role in the industry.
✨
Analysis of M&A targets: Viking, Verona, Altimmune.
Edwin Elmhirst
Joseph Haas
Kevin Grogan
✨
Anita Nahal discusses consumers seeking reliable health information sources.
Anita Nahal
✨
Healis Therapeutics CEO discusses treating depression with Botox.
Facial Botox Injections
✨
Teva launches immunology biosimilar; Intra-Cellular shows depression data.
✨
Medicare spending projections for Alzheimer's treatment Leqembi are discussed.
✨
Imspex introduces a new diagnostic technology using breath analysis.
✨
Ratio Therapeutics discusses its radiopharmaceuticals pipeline and BMS investment.
Jack Hoppin
John Babich
✨
Updates on the proposed US BIOSECURE Act and US-China biotech movements are discussed.
Ali Parshadezah
Brian Yang
Dexter Yan
✨
Pharma R&D strategies and oncology focus are shifting.
Drug Fix: US FDA Adcomm Open Public Hearings, Clinical Trial Diversity Plans, Stealth’s Elamipretide
✨
Richard Pazdur calls for diverse opinions in FDA advisory committee hearings.
✨
Hanadie Yousef discusses Juvena Therapeutics, secretomes, and longevity medicine.
Hanadie Yousef
✨
Genmab invests in ADCs; Roivant challenges AbbVie in uveitis.
✨
Amylyx withdraws Relyvrio post-trial failure, potentially inspiring more pledges.
✨
Industry professionals share insights from HIMSS 2024.
Hannah Daniel
✨
Korean ADC companies strive to advance the ecosystem.
✨
Merck & Co advances cardiovascular strategy.
✨
Analyzing the trend of spin-outs in consumer health.
Malcolm Spicer
Tom Gallen